Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

US House panel critical of Twitter probe to question FTC chair at July 13 hearing

Published 06/23/2023, 04:32 PM
Updated 06/23/2023, 07:15 PM
© Reuters. FILE PHOTO: FTC Commissioner nominee Lina M. Khan testifies during a Senate Commerce, Science, and Transportation Committee hearing on the nomination of Former Senator Bill Nelson to be NASA administrator, on Capitol Hill in Washington, U.S., April 21, 20
AMZN
-
ILMN
-
TSLA
-

By David Shepardson

WASHINGTON (Reuters) -U.S. Federal Trade Commission Chair Lina Khan is set to testify on July 13 before the House Judiciary Committee led by Republicans who have sharply criticized her leadership of the antitrust enforcement agency, the committee and commission confirmed on Friday.

This will be her first appearance before the committee since Republicans assumed control.

Republicans have been especially critical of the FTC's privacy investigation into Twitter since it was purchased by billionaire Tesla (NASDAQ:TSLA) CEO Elon Musk.

In March, the FTC confirmed it was conducting an investigation into Twitter’s privacy practices. The agency has been concerned whether Twitter had the staffing to abide by a May 2022 settlement with the FTC in which it agreed to improve its privacy practices.

In April, the committee subpoenaed Khan for documents related to the Twitter privacy probe following Musk's $44 billion purchase of the social media company in October.

House Judiciary Committee chair Jim Jordan suggested in a June 8 letter "there is an unjustified approximate one-year gap in the FTC’s actions with respect to Twitter" and added it was reasonable to conclude neither the prior chair nor Khan "seriously planned to take action against Twitter "until political pressure arose given Mr. Musk’s impending acquisition."

Jordan in February also questioned the FTC's plans to adopt a new rule to ban noncompete clauses for workers and its approach to the merger of Illumina (NASDAQ:ILMN) and Grail.

San Diego-based Illumina, which specializes in gene sequencing, is appealing an FTC order that said the company's $7.1 billion acquisition of Grail will curb competition in the cancer-testing market. Illumina has denied the allegations.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The FTC, which typically has five commissions including two from the minority party, currently has just three Democratic commissioners after Christine Wilson stepped down at the end of March.

Khan, an antitrust researcher focused on Big Tech’s immense market power, vowed to reinvigorate antitrust enforcement after she joined the FTC in June 2021 and was named chair.

This week the FTC sued Amazon.com (NASDAQ:AMZN) accusing it of enrolling millions of consumers into its paid subscription Amazon Prime service without their consent and making it hard for them to cancel.

Politico first reported the plans for the hearing.

Latest comments

elon fired all the staffs meant to do this...
Hi
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.